AstraZeneca says Nexium pills with Ranbaxy ingredient are safe to use

While most drugs from India are generics, sometimes Big Pharma uses Indian products for their top brands, like AstraZeneca's ($AZN) Nexium. The U.K.-based drugmaker told Bloomberg that its stomach pills on the market are safe to use and that it is no longer buying any of the active pharmaceutical ingredient (API) for it from the Ranbaxy Laboratories plant that the FDA banned in January, Bloomberg reports. As AstraZeneca pointed out, despite the ban, the FDA did not recall any Ranbaxy products. The FDA banned the facility after inspectors found it was retesting products until it got the test results needed for them to pass and then deleting the failed tests from computers. AstraZeneca said it was already getting some of the API from a facility in France and is now sourcing it from there exclusively. "As we would in response to any regulatory action of this sort, we have carried out rigorous quality-control checks to ensure U.S. Nexium meets our quality standards," spokeswoman Vanessa Rhodes told Bloomberg. Story | More

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.